Industries > Pharma > Global Antifungal Drugs Market Forecast 2019-2029

Global Antifungal Drugs Market Forecast 2019-2029

Azoles, Echinocandins, Polyenes, Allylamines, Voriconazole, Posaconazole, Clotrimazole, Isavuconazole, Fluconazole, Caspofungin, Micagunfin, Amphotericin, Lamisil, Dermatophytosis, Aspergillosis, Candidiasis

PUBLISHED: 04 June 2019
PAGES: 203
PRODUCT CODE: PHA0425
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0425 Categories: , Tags: , , ,

The global antifungal drugs market is estimated to have reached $14bn in 2018 and is expected to grow at a CAGR of 3.8% during the forecast period. In 2018, the global antifungal drugs market was dominated by Azoles.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 203-page report you will receive 85 tables and 101 figures– all unavailable elsewhere.

The 203-page report provides clear detailed insight into the antifungal drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Antifungal Drugs Market forecasts from 2019-2029

• Global Antifungal Drugs Market forecasts from 2019-2029 by Segment:
• Azoles
• Echinocandins
• Polyenes
• Allylamines
• Others

• Global Antifungal Drugs Market forecasts from 2019-2029 by Indication:
• Dermatophytosis
• Aspergillosis
• Candidiasis
• Others

• Global Antifungal Drugs Market forecasts from 2019-2029 by Drugs:
• Voriconazole
• Posaconazole
• Clotrimazole
• Isavuconazole
• Fluconazole
• Caspofungin
• Micagunfin
• Amphotericin
• Lamisil

• Global Antifungal Drugs Market forecasts from 2019-2029 by regional and national market:
• North America: The U.S., Canada
• Europe: Germany, France, the UK, Italy, Spain, Rest of Europe
• Asia-Pacific: Japan, China, India, Rest of APAC
• Latin America: Brazil, Mexico, Rest of Latin America

Global Antifungal Drugs Market Forecast 2019-2029

Each regional market is further segmented into Azoles, Echinocandins, Polyenes, Allylamines, Dermatophytosis, Aspergillosis, Candidiasis, Others

• Profiles of the selected leading companies:
• Abbott Laboratories
• Bayer AG
• Enzon Pharmaceuticals, Inc.
• Gilead Sciences, Inc.
• GlaxoSmithKline
• Kramer Laboratories, Inc.
• Merck & Co., Inc.
• Novartis AG
• Pfizer
• Sanofi S.A.

• Antifungal Drugs R&D Pipeline

• Key Questions Answered by this Report:
• How is the Antifungal Drugs market evolving?
• How will each Antifungal Drugs submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2029?
• How will the market shares for each Antifungal Drugs submarket develop from 2019 to 2029?
• Will leading national Antifungal Drugs markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2029 and which geographical region will lead the market in 2029?
• Who are the leading players?
• How will the industry evolve during the period between 2019 and 2029?

Visiongain’s study is intended for anyone requiring commercial analyses for the global antifungal drugs Market. You find data, trends and predictions.

Buy our report today Global Antifungal Drugs Market Analysis: Azoles, Echinocandins, Polyenes, Allylamines, Voriconazole, Posaconazole, Clotrimazole, Isavuconazole, Fluconazole, Caspofungin, Micagunfin, Amphotericin, Lamisil, Dermatophytosis, Aspergillosis, Candidiasis.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Antifungal Drugs Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Antifungal Drugs Market Forecast 2019-2029


Latest Pharma news

Visiongain Publishes Biological API Manufacturing Services Market Report 2021-2031

Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.

08 January 2021

READ

Visiongain Publishes Anaesthesia & Respiratory Devices Market Report 2020-2030

The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in respiratory and anesthesia devices. However, unfavourable reimbursement policies and lack of patient adherence in respiratory diseases are some of the factors restraining the growth of the anesthesia and respiratory devices market.

07 January 2021

READ

Visiongain Publishes Inactivated Vaccines Market Report 2020-2030

Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine development are driving the growth of this market. While high cost of vaccine development is the key factor emerging as a growth barrier over years in this market.

07 January 2021

READ

Visiongain Publishes Human Microbiome Therapeutics Market Report 2021-2031

The potential of microbiome-based drugs as novel treatments to address the unmet needs for many diseases has contributed intensively to the rapid emergence of many investors in this area. Currently, no regulatory framework exists and no drugs have received FDA approval. However, there are several preclinical and clinical-stage companies working with various approaches to develop microbiome-based therapies.

06 January 2021

READ

Categories

Category